BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30453799)

  • 21. Herbal compound triptolide synergistically enhanced antitumor activity of amino-terminal fragment of urokinase.
    Lin Y; Peng N; Li J; Zhuang H; Hua ZC
    Mol Cancer; 2013 Jun; 12():54. PubMed ID: 23758884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triptolide induces S phase arrest via the inhibition of cyclin E and CDC25A and triggers apoptosis via caspase- and mitochondrial-dependent signaling pathways in A375.S2 human melanoma cells.
    Hung FM; Chen YL; Huang AC; Hsiao YP; Yang JS; Chung MT; Chueh FS; Lu HF; Chung JG
    Oncol Rep; 2013 Mar; 29(3):1053-60. PubMed ID: 23314229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of microRNA-1271 on ovarian cancer via inhibition of epithelial-mesenchymal transition and cisplatin resistance.
    Chen Y; Wang L; Zhou J
    J Obstet Gynaecol Res; 2019 Nov; 45(11):2243-2254. PubMed ID: 31411791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined Treatment with Triptolide and Tyrosine Kinase Inhibitors Synergistically Enhances Apoptosis in Non-small Cell Lung Cancer H1975 Cells but Not H1299 Cells through EGFR/Akt Pathway.
    Tong X; Jiang P; Li Y; Guo L; Zhang HM; Zhang BK; Yan M
    Chem Pharm Bull (Tokyo); 2019 Aug; 67(8):864-871. PubMed ID: 31142691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triptolide enhances the sensitivity of multiple myeloma cells to dexamethasone via microRNAs.
    Huang X; Yang M; Jin J
    Leuk Lymphoma; 2012 Jun; 53(6):1188-95. PubMed ID: 22260163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression.
    Huang W; He T; Chai C; Yang Y; Zheng Y; Zhou P; Qiao X; Zhang B; Liu Z; Wang J; Shi C; Lei L; Gao K; Li H; Zhong S; Yao L; Huang ME; Lei M
    PLoS One; 2012; 7(5):e37693. PubMed ID: 22666381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triptolide inhibits pituitary adenoma cell viability, migration and invasion via ADAM12/EGFR signaling pathway.
    Wang J; Zhang Z; Li R; Sun W; Chen J; Zhang H; Shu K; Lei T
    Life Sci; 2018 Feb; 194():150-156. PubMed ID: 29288766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schizandrin A inhibits proliferation, migration and invasion of thyroid cancer cell line TPC-1 by down regulation of microRNA-429.
    Ding Q; Li X; Sun Y; Zhang X
    Cancer Biomark; 2019; 24(4):497-508. PubMed ID: 30909188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic antitumour effects of triptolide plus 10-hydroxycamptothecin onbladder cancer.
    Wang T; Ding Y; Yang Y; Wang Z; Gao W; Li D; Wei J; Sun Y
    Biomed Pharmacother; 2019 Jul; 115():108899. PubMed ID: 31063955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.
    Sai K; Li WY; Chen YS; Wang J; Guan S; Yang QY; Guo CC; Mou YG; Li WP; Chen ZP
    Am J Chin Med; 2014; 42(2):485-503. PubMed ID: 24707876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells.
    Li H; Takai N; Yuge A; Furukawa Y; Tsuno A; Tsukamoto Y; Kong S; Moriyama M; Narahara H
    Cancer Lett; 2010 Nov; 297(2):198-206. PubMed ID: 20547442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triptolide induces apoptosis in human adrenal cancer NCI-H295 cells through a mitochondrial-dependent pathway.
    Wu PP; Liu KC; Huang WW; Ma CY; Lin H; Yang JS; Chung JG
    Oncol Rep; 2011 Feb; 25(2):551-7. PubMed ID: 21152873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triptolide reverses the Taxol resistance of lung adenocarcinoma by inhibiting the NF-κB signaling pathway and the expression of NF-κB-regulated drug-resistant genes.
    Jiang N; Dong XP; Zhang SL; You QY; Jiang XT; Zhao XG
    Mol Med Rep; 2016 Jan; 13(1):153-9. PubMed ID: 26531258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triptolide antagonized the cisplatin resistance in human ovarian cancer cell line A2780/CP70 via hsa-mir-6751.
    Wang R; Ma X; Su S; Liu Y
    Future Med Chem; 2018 Aug; 10(16):1947-1955. PubMed ID: 29966441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triptolide triggers the apoptosis of pancreatic cancer cells via the downregulation of Decoy receptor 3 expression.
    Wang W; Li X; Sun W; Zhang L; Zhang M; Hong B; Lv G
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1597-605. PubMed ID: 22581262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EMT-related protein expression in polyploid giant cancer cells and their daughter cells with different passages after triptolide treatment.
    Wang X; Zheng M; Fei F; Li C; Du J; Liu K; Li Y; Zhang S
    Med Oncol; 2019 Aug; 36(9):82. PubMed ID: 31407170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells.
    Li SG; Shi QW; Yuan LY; Qin LP; Wang Y; Miao YQ; Chen Z; Ling CQ; Qin WX
    J Exp Clin Cancer Res; 2018 Mar; 37(1):51. PubMed ID: 29523159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy.
    Zheng Y; Kong F; Liu S; Liu X; Pei D; Miao X
    Drug Deliv; 2021 Dec; 28(1):2033-2043. PubMed ID: 34569906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMD3100 combined with triptolide inhibit proliferation, invasion and metastasis and induce apoptosis of human U2OS osteosarcoma cells.
    Jiang C; Fang X; Zhang H; Wang X; Li M; Jiang W; Tian F; Zhu L; Bian Z
    Biomed Pharmacother; 2017 Feb; 86():677-685. PubMed ID: 28038429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triptolide induced DNA damage in A375.S2 human malignant melanoma cells is mediated via reduction of DNA repair genes.
    Chueh FS; Chen YL; Hsu SC; Yang JS; Hsueh SC; Ji BC; Lu HF; Chung JG
    Oncol Rep; 2013 Feb; 29(2):613-8. PubMed ID: 23233170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.